BALANCE OF METABOLIC NEUTRALITY AND ANTIHYPERTENSIVE THERAPY EFFICIENCY
- Authors: Shishkova V.1
-
Affiliations:
- Center for Speech Pathology and Neurorehabilitation
- Issue: Vol 23, No 4 (2012)
- Pages: 37-42
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/115438
- ID: 115438
Cite item
Open Access
Access granted
Abstract
The benefits of fixed-dose antihypertensive combinations are the mutual potentiation of the effects of their involved drugs; the larger number of patients achieving goal blood pressure; fewer adverse reactions; no use of irrational combinations; less treatment cost; and thus higher treatment adherence.
Keywords
Full Text
About the authors
V. Shishkova
Center for Speech Pathology and Neurorehabilitation
Email: veronika-1306@mail.ru
Candidate of Medical Sciences
References
- Prisant L.M., Weir M.R., Papademetriou V. et al. Low-dose drug combination therapy: an alternative first-line approach to hypertension treatment Am Heart J. 1995; 130: 359-366.
- Weir M.R., Prisant L.M., PapademetriouV. et al. Low-dose combination treatment for hypertension vs single-drug treatment— bisoprolol/ Hydrochlorothiazide vs Amlodipine, Enalapril, and placebo: Combined anylisis of comparative studies. AmJTher. 1996;5:313-321.
- Чазова И.Е. и др. Системные гипертензии №4,2010; 72-74.
- Reaven G. Banting lecture 1988. Role of insulin resistance in human disease // Diabetes. - 1988; 37: 1595-1607.
- American Diabetic Association. Insulin resistance // Diabetes Care. - 1998; 21: 310-314.
- Диагностика и лечение артериальной гипертензии. Российские рекомендации (4-й пересмотр) // Системн. гипертенз. - 2010; 3: 3-25.
- Zillich A. J., Garg J., Basu S. et al. Thiazide diuretics, potassium, and the development of diabetes: a quantitative review // Hypertension. - 2006; 48: 219-224.
- Bakris G., Molitch M., Hewkin A. et al. STAR Investigators. Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome // Diabetes. Care. - 2006; 29: 2592-2597.
- Helderman J., Elahi D., Andersen D. et al. Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium // Diabetes. - 1983; 32: 106-111.
- Wright G., Musini V. First-line drugs for hypertension // Cochrane Library. -2009; CD001841: 1-59.
- Frishman W., Bryzinski B., Coulson L. et al. A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide // Arch. Intern. Med. - 1994; 154 (13): 1461-1468.
- Prisant L., Neutel J., Papademetriou V. et al. Low-dose combination treatment for hypertension versus single-drug treatment-bisoprolol/hydrochlorothiazide versus amlodipine, enalapril, and placebo: combined analysis of comparative studies // Am. J. Ther. - 1998; 5: 313-321.
- Lewin A., Leug M., Targum S. et al. A clinical trial evaluating the 24-hour effects of bisoprolol/hydrochlorothiazide 5 mg/6,25 mg combination in patients with mild to moderate hypertension // Clin. Cardiol. - 1993; 16: 732-736.
- Benetos A., Adamopoulos C., Argyriadis P. et al. Clinical results with bisoprolol 2.5 mg/hydrochlorothiazide 6.25 mg combination in systolic hypertension in the elderly // Hypertens. Suppl. - 2002; 20 (1): 21-25.
- И. Е. Чазова, Л. Г. Ратова. Фиксированная комбинация β-блокатора и диуретика в лечении больных // Системные гипертензии. - 2010; 4: 25-28.
Supplementary files
